COVID-19 Infection and Vaccination in Pediatric Demyelinating Diseases: Research Findings
Children with demyelinating diseases, such as multiple sclerosis, anti-myelin oligodendrocyte glycoprotein associated disease, and neuromyelitis optica spectrum disorder, are at a higher risk of severe COVID-19 infection. A new study published in Pediatric Neurology has found that COVID-19 vaccination does not increase the risk of neuroinflammatory events in children with demyelinating diseases. The research suggests that further studies are needed to understand the effects of COVID-19 infection and vaccination on children and adults with demyelinating diseases.
Key Takeaways:
- The study found that 26% of children with demyelinating diseases had a known COVID-19 infection, with 10% of those infected being hospitalized.
- None of the children hospitalized required intubation or ICU admission.
- SARS-CoV-2 vaccination was not associated with any new onset or relapse neuroinflammatory events in the cohort.
- Demyelinating diagnosis and anti-CD20 mAbs were associated with known SARS-CoV-2 infection.
- Two participants had an initial clinical MS event associated with infection, but no association was found with SARS-COV-2 vaccination or infection with relapses.
- The study concluded that larger multicenter studies are needed to prospectively compare how infection and vaccination affects children and adults with demyelinating diseases.
Statistics:
- 116 children with demyelinating diagnoses were included in the study.
- 30 out of 116 (26%) children had a known COVID-19 infection.
- 3 out of 30 (10%) of those with known infection were hospitalized.
- 2 out of 30 (7%) had neuroinflammatory events that occurred within four weeks of infection.
- No children required intubation or ICU admission.
Sources:
- NewsRx. Investigators at Emory University Report Findings in COVID-19 (Coronavirus Disease 2019 Infection and Vaccination In Pediatric Demyelinating Diseases). Pediatrics Week. June 21, 2025; p 67.
- Coronavirus Disease 2019 Infection and Vaccination In Pediatric Demyelinating Diseases. Pediatric Neurology, 2025;168:13-16.